Editorial
 BEARING RANBAXY BURDEN   
 Wednesday, April 23, 2014 
 The takeover of Daiichi Sankyo owned Ranbaxy Labs by Sun Pharmaceuticals for $4 billion including a $800 million liability early this month surprised quite a few in the Indian pharmaceutical industry. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Novartis to present data from Gilenya on four key measures of MS disease activity at AAN meeting
17:00  [IST]US FDA grants orphan drug status to Emergent BioSolutions' BioThrax for PEP of anthrax disease
16:30  [IST]Medwell Ventures forays into home health market, to invest Rs.120 crore in 5 years
16:00  [IST]Study results indicate Acthar may reduce proteinuria in patients with nephrotic syndrome due to idiopathic membranous nephropathy
15:00  [IST]US FDA accepts Gilead’s NDA for cobicistat & elvitegravir for HIV therapy
14:20  [IST]Dr Reddy’s launches generic Antara capsules in US market
more news >>
TOP NEWS
08:00  [IST]Govt to further restrict manufacture, sale of oxytocin injection
08:00  [IST]Indian Pharmacopoeia-2014 comes into force
08:00  [IST]Hospital pharmacists in UP urges state govt to appoint pharmacists in PHCs, allow them to handle emergencies
08:00  [IST]Crocin Advance at DPCO price may take some time to reach retail outlets
08:00  [IST]Karnataka to spend Rs.431.9 cr for treating non communicable diseases, moots preventive health drive
08:00  [IST]NPPA sends notices in 89 cases of overcharging to recover Rs.384 cr during last year
more news >>
YESTERDAY'S NEWS
18:00  [IST]DePuy Synthes introduces patient specific plates for mandible
17:00  [IST]India not to budge under US pressure on IPR issues
16:45  [IST]Narayana Health City performs 300 bone marrow transplants, records 80 % success
16:30  [IST]Fortis Malar Hospital in association with IMA Conducts CME in ‘Tribute to Asthma’
16:00  [IST]Chindex signs amended merger agreement with TPG & Fosun Pharma
15:00  [IST]Sagent Pharma reintroduces Adenosine injection, USP
more news >>
INTERVIEW  
Knowledge empowerment of pharmacist would drive to achieve Pharma Vision 2020
DA Gundu Rao, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is price control a deterrent to investment in Indian pharmaceutical sector as is being cited by a US govt report?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |